Obesogenic memory can confer long-term increases in adipose tissue but not liver inflammation and insulin resistance after weight loss

Molecular Metabolism

Volumn 5, Issue 5, 2016, Pages 328-339

  Schmitz, J ^a,b,c,d   Evers, N ^a,b,c,d   Awazawa, M ^a,b,c,d   Nicholls, H T ^a,b,c,d   Bronneke H S ^a,b,c,d   Dietrich, A ^e   Mauer, J ^a,b,c,d   Bluher M ^e   Bruning J C ^a,b,c,d  

^a MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^e UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Insulin resistance; Metabolic inflammation; Obesity; Weight loss; Weight regain

Indexed keywords

INSULIN;

ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; BARIATRIC SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HEPATITIS; HORMONE ACTION; HUMAN; HUMAN TISSUE; HYPERPHAGIA; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LEAN BODY WEIGHT; LIPID DIET; LIVER; MALE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 84959506635     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.12.001     Document Type: Article

References (47)

1. Finucane M.M., Stevens G.A., Cowan M.J., Danaei G., Lin J.K., Paciorek C.J., et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet 2011, 377:557-567. 10.1016/S0140-6736(10)62037-5.
2. Stevens G.A., Singh G.M., Lu Y., Danaei G., Lin J.K., Finucane M.M., et al. National, regional, and global trends in adult overweight and obesity prevalences. Population Health Metrics 2012, 10:22. 10.1186/1478-7954-10-22.
3. W.H. Organisation, 2013 (n.d.). http://www.who.int/mediacentre/factsheets/fs311/en/index.html.
4. Flegal K.M., Graubard B.I., Williamson D.F., Gail M.H. Cause-specific excess deaths associated with underweight, overweight, and obesity. Journal of American of Medical Association 2007, 298:2028-2037. 10.1001/jama.298.17.2028.
5. Leblanc E.S., O'Connor E., Whitlock E.P., Patnode C.D., Kapka T. Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2011, 155:434-447. 10.7326/0003-4819-155-7-201110040-00006.
6. Tuomilehto J., Lindström J., Eriksson J.G., Valle T.T., Hämäläinen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. The New England Journal of Medicine 2001, 344:1343-1350. 10.1056/NEJM200105033441801.
7. Stevens V.J., Obarzanek E., Cook N.R., Lee I.M., Appel L.J., Smith West D., et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Annals of Internal Medicine 2001, 134:1-11.
8. Shaw K., Gennat H., O'Rourke P., Del Mar C. Exercise for overweight or obesity. Cochrane Database of Systematic Reviews 2006, CD003817. 10.1002/14651858.CD003817.pub3.
9. Thorogood A., Mottillo S., Shimony A., Filion K.B., Joseph L., Genest J., et al. Isolated aerobic exercise and weight loss: a systematic review and meta-analysis of randomized controlled trials. American Journal of Medicine 2011, 124:747-755. 10.1016/j.amjmed.2011.02.037.
10. Sacks F.M., Bray G.A., Carey V.J., Smith S.R., Ryan D.H., Anton S.D., et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. The New England Journal of Medicine 2009, 360:859-873. 10.1056/NEJMoa0804748.
11. Shai I., Schwarzfuchs D., Henkin Y., Shahar D.R., Witkow S., Greenberg I., et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. The New England Journal of Medicine 2008, 359:229-241. 10.1056/NEJMoa0708681.
12. The Look AHEAD Research Group Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. The New England Journal of Medicine 2013, 369:145-154. 10.1056/NEJMoa1212914.
13. Bray G.A., Bouchard C. Handbook of obesity 2003, CRC Press.
14. Wing R.R., Hill J.O. Successful weight loss maintenance. Annual Review of Nutrition 2001, 21:323-341. 10.1146/annurev.nutr.21.1.323.
15. Wadden T.A., Stunkard A.J. Handbook of obesity treatment 2004, Guilford Press.
16. Leibel R.L., Rosenbaum M., Hirsch J. Changes in energy expenditure resulting from altered body weight. The New England Journal of Medicine 1995, 332:621-628. 10.1056/NEJM199503093321001.
17. Rosenbaum M., Hirsch J., Gallagher D.A., Leibel R.L. Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. American Journal of Clinical Nutrition 2008, 88:906-912.
18. Camps S.G.J.A., Verhoef S.P.M., Westerterp K.R. Weight loss, weight maintenance, and adaptive thermogenesis. American Journal of Clinical Nutrition 2013, 97:990-994. 10.3945/ajcn.112.050310.
19. Astrup A., Gøtzsche P.C., van de Werken K., Ranneries C., Toubro S., Raben A., et al. Meta-analysis of resting metabolic rate in formerly obese subjects. American Journal of Clinical Nutrition 1999, 69:1117-1122.
20. Schwartz A., Kuk J.L., Lamothe G., Doucet E. Greater than predicted decrease in resting energy expenditure and weight loss: results from a systematic review. Obesity (Silver Spring) 2012, 20:2307-2310. 10.1038/oby.2012.34.
21. Ochner C.N., Barrios D.M., Lee C.D., Pi-Sunyer F.X. Biological mechanisms that promote weight regain following weight loss in obese humans. Physiology & Behavior 2013, 120:106-113. 10.1016/j.physbeh.2013.07.009.
22. Maclean P.S. Enhanced metabolic efficiency contributes to weight regain after weight loss in obesity-prone rats. AJP: Regulatory, Integrative and Comparative Physiology 2004, 287:R1306-R1315. 10.1152/ajpregu.00463.2004.
23. Maclean P.S. Metabolic adjustments with the development, treatment, and recurrence of obesity in obesity-prone rats. AJP: Regulatory, Integrative and Comparative Physiology 2004, 287:R288-R297. 10.1152/ajpregu.00010.2004.
24. Turpin S.M., Nicholls H.T., Willmes D.M., Mourier A., Brodesser S., Wunderlich C.M., et al. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance. Cell Metabolism 2014, 20:678-686. 10.1016/j.cmet.2014.08.002.
25. Kannt A., Pfenninger A., Teichert L., Tönjes A., Dietrich A., Schön M.R., et al. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance. Diabetologia 2015, 58:799-808. 10.1007/s00125-014-3490-7.
26. Kloting N., Fasshauer M., Dietrich A., Kovacs P., Schon M.R., Kern M., et al. Insulin-sensitive obesity. AJP: Endocrinology and Metabolism 2010, 299:E506-E515. 10.1152/ajpendo.00586.2009.
27. Mauer J., Chaurasia B., Plum L., Quast T., Hampel B., Blüher M., et al. Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance. PLoS Genetics 2010, 6:e1000938. 10.1371/journal.pgen.1000938.
28. Lang R., Patel D., Morris J.J., Rutschman R.L., Murray P.J. Shaping gene expression in activated and resting primary macrophages by IL-10. Journal of Immunology 2002, 169:2253-2263.
29. Vogt M.C., Paeger L., Hess S., Steculorum S.M., Awazawa M., Hampel B., et al. Neonatal insulin action impairs hypothalamic neurocircuit formation in response to maternal high-fat feeding. Cell 2014, 156:495-509. 10.1016/j.cell.2014.01.008.
30. Kornfeld J.-W., Baitzel C., Könner A.C., Nicholls H.T., Vogt M.C., Herrmanns K., et al. Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature 2013, 494:111-115. 10.1038/nature11793.
31. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444:840-846. 10.1038/nature05482.
32. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.-W., Long J.M., et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nature Medicine 2005, 11:191-198. 10.1038/nm1185.
33. Wunderlich F.T., Ströhle P., Könner A.C., Gruber S., Tovar S., Brönneke H.S., et al. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. Cell Metabolism 2010, 12:237-249. 10.1016/j.cmet.2010.06.011.
34. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Journal of Clinical Investigation 2003, 112:1821-1830. 10.1172/JCI19451.
35. Mauer J., Chaurasia B., Goldau J., Vogt M.C., Ruud J., Nguyen K.D., et al. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nature Immunology 2014, 15:423-430. 10.1038/ni.2865.
36. Tirosh A., Shai I., Afek A., Dubnov-Raz G., Ayalon N., Gordon B., et al. Adolescent BMI trajectory and risk of diabetes versus coronary disease. The New England Journal of Medicine 2011, 364:1315-1325. 10.1056/NEJMoa1006992.
37. Saisho Y., Butler A.E., Manesso E., Elashoff D., Rizza R.A., Butler P.C. β-cell mass and turnover in humans: effects of obesity and aging. Diabetes Care 2013 Jan, 36(1):111-117. 10.2337/dc12-0421/-/DC1.
38. Weyer C., Hanson K., Bogardus C., Pratley R.E. Long-term changes in insulin action and insulin secretion associated with gain, loss, regain and maintenance of body weight. Diabetologia 2000, 43:36-46. 10.1007/s001250050005.
39. Holte J., Bergh T., Berne C., Wide L., Lithell H. Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism 1995, 80:2586-2593. 10.1210/jcem.80.9.7673399.
40. Vahl T.P., Aulinger B.A., Smith E.P., Drazen D.L., Ulrich-Lai Y., Seeley R.J., et al. Meal feeding improves oral glucose tolerance in male rats and causes adaptations in postprandial islet hormone secretion that are independent of plasma incretins or glycemia. AJP: Endocrinology and Metabolism 2014, 307:E784-E792. 10.1152/ajpendo.00339.2014.
41. Kirchner H., Hofmann S.M., Fischer-Rosinský A., Hembree J., Abplanalp W., Ottaway N., et al. Caloric restriction chronically impairs metabolic programming in mice. Diabetes 2012, 61:2734-2742. 10.2337/db11-1621.
42. Montecucco F., Lenglet S., Quercioli A., Burger F., Thomas A., Lauer E., et al. Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways. Thrombosis and Haemostasis 2015, 113:838-850. 10.1160/TH14-06-0506.
43. Trachta P., Dostalova I., Haluzikova D., Kasalicky M., Kavalkova P., Drapalova J., et al. Laparoscopic sleeve gastrectomy ameliorates mRNA expression of inflammation-related genes in subcutaneous adipose tissue but not in peripheral monocytes of obese patients. Molecular and Cellular Endocrinology 2014, 383:96-102. 10.1016/j.mce.2013.11.013.
44. Lakhdar N., Denguezli M., Zaouali M., Zbidi A., Tabka Z., Bouassida A. Diet and diet combined with chronic aerobic exercise decreases body fat mass and alters plasma and adipose tissue inflammatory markers in obese women. Inflammation 2013, 36:1239-1247. 10.1007/s10753-013-9661-8.
45. Moschen A.R., Molnar C., Geiger S., Graziadei I., Ebenbichler C.F., Weiss H., et al. Anti-inflammatory effects of excessive weight loss: potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression. Gut 2010, 59:1259-1264. 10.1136/gut.2010.214577.
46. Cancello R., Henegar C., Viguerie N., Taleb S., Poitou C., Rouault C., et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005, 54:2277-2286. 10.2337/diabetes.54.8.2277.
47. Only C-reactive protein, but not TNF-alpha or IL6, reflects the improvement in inflammation after bariatric surgery. Obesity Surgery 2012, 22:131-139. 10.1007/s11695-011-0546-3.